MCATs Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Funding
• Clinical Trials
• Forums

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the Investigational GSK Biologicals' GSK3277511A Vaccine in Adults.
Condition:   Respiratory DisordersInterventions:   Biological: Formulation 1 (plain) NTHi/Mcat vaccine GSK3277513A;   Biological: Formulation 2 (adjuvanted) NTHi/Mcat vaccine GSK3277513A;   Biological: Formulation 3 (adjuvanted) NTHi/Mcat vaccine GSK3339036A;   Drug: Placebo comparatorSponsor:   GlaxoSmithKlineRecruiting - verified September 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2015 Category: Research Source Type: clinical trials

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the Investigational GSK Biologicals' GSK3277511A Vaccine in Adults.
Condition:   Respiratory DisordersInterventions:   Biological: Formulation 1 (plain) NTHi/Mcat vaccine GSK3277513A;   Biological: Formulation 2 (adjuvanted) NTHi/Mcat vaccine GSK3277513A;   Biological: Formulation 3 (adjuvanted) NTHi/Mcat vaccine GSK3339036A;   Drug: PlaceboSponsor:   GlaxoSmithKlineRecruiting - verified September 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2015 Category: Research Source Type: clinical trials

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the Investigational GSK Biologicals' GSK3277511A Vaccine in Adults.
Condition:   Respiratory DisordersInterventions:   Biological: Formulation 1 (plain) NTHi/Mcat vaccine GSK3277513A;   Biological: Formulation 2 (adjuvanted) NTHi/Mcat vaccine GSK3277513A;   Biological: Formulation 3 (adjuvanted) NTHi/Mcat vaccine GSK3339036A;   Drug: Placebo comparatorSponsor:   GlaxoSmithKlineRecruiting - verified September 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2015 Category: Research Source Type: clinical trials

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the Investigational GSK Biologicals' GSK3277511A Vaccine in Adults.
Condition:   Respiratory DisordersInterventions:   Biological: Formulation 1 (plain) NTHi/Mcat vaccine GSK3277513A;   Biological: Formulation 2 (adjuvanted) NTHi/Mcat vaccine GSK3277513A;   Biological: Formulation 3 (adjuvanted) NTHi/Mcat vaccine GSK3339036A;   Drug: PlaceboSponsor:   GlaxoSmithKlineRecruiting - verified September 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2015 Category: Research Source Type: clinical trials